Literature DB >> 8401923

Pharmacological characterization of acetylcholine-stimulated [35S]-GTP gamma S binding mediated by human muscarinic m1-m4 receptors: antagonist studies.

S Lazareno1, N J Birdsall.   

Abstract

1. We have used dose-ratio analysis to estimate functionally the affinity constants (pKb) and Schild slope factors of a range of selective or atypical antagonists at human muscarinic m1-m4 receptors. 2. The functional response was the stimulation by acetylcholine of [35S]-GTP gamma S binding to membranes from Chinese hamster ovary (CHO) cells stably expressing individual receptor subtypes. 3. A novel experimental design and analysis was used which allowed the estimation of affinity and Schild slope factor from a single antagonist inhibition curve, and the results were compared with other methods of analysis, both theoretically valid and invalid. 4. In general, the affinity estimates were very similar to previously reported values obtained in binding studies with animal tissues and cloned human receptors and the Schild slope factors were close to unity. 5. These results demonstrate the validity of the assay and provide no evidence for species differences in antagonist affinity for muscarinic receptor subtypes. 6. The results confirm both the utility of himbacine in distinguishing between m1 and m4 receptors and a previously reported modest m4-selectivity for tropicamide and secoverine. 7. The cholinesterase inhibitor, tacrine (THA), had a potency profile similar to that of gallamine but with less selectivity. Its affinity could not be determined since it had Schild slope factors of about 2 at all subtypes. 8. o-Methoxy-sila-hexocyclium had only a modest selectivity for the m1 subtype.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8401923      PMCID: PMC2175752          DOI: 10.1111/j.1476-5381.1993.tb13738.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  44 in total

Review 1.  Molecular properties of the muscarinic acetylcholine receptor.

Authors:  N M Nathanson
Journal:  Annu Rev Neurosci       Date:  1987       Impact factor: 12.449

2.  An M2 muscarinic receptor subtype coupled to both adenylyl cyclase and phosphoinositide turnover.

Authors:  A Ashkenazi; J W Winslow; E G Peralta; G L Peterson; M I Schimerlik; D J Capon; J Ramachandran
Journal:  Science       Date:  1987-10-30       Impact factor: 47.728

3.  Functionally distinct G proteins selectively couple different receptors to PI hydrolysis in the same cell.

Authors:  A Ashkenazi; E G Peralta; J W Winslow; J Ramachandran; D J Capon
Journal:  Cell       Date:  1989-02-10       Impact factor: 41.582

4.  Mechanisms of muscarinic receptor action on Go in reconstituted phospholipid vesicles.

Authors:  V A Florio; P C Sternweis
Journal:  J Biol Chem       Date:  1989-03-05       Impact factor: 5.157

5.  Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.

Authors:  T Kenakin; C Boselli
Journal:  J Pharmacol Exp Ther       Date:  1989-09       Impact factor: 4.030

6.  o-Methoxy-sila-hexocyclium: a new quaternary M1-selective muscarinic antagonist.

Authors:  G Lambrecht; G Gmelin; K Rafeiner; C Strohmann; R Tacke; E Mutschler
Journal:  Eur J Pharmacol       Date:  1988-06-22       Impact factor: 4.432

7.  Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.

Authors:  N J Buckley; T I Bonner; C M Buckley; M R Brann
Journal:  Mol Pharmacol       Date:  1989-04       Impact factor: 4.436

8.  Muscarinic acetylcholine receptor-stimulated binding of guanosine 5'-O-(3-thiotriphosphate) to guanine-nucleotide-binding proteins in cardiac membranes.

Authors:  G Hilf; P Gierschik; K H Jakobs
Journal:  Eur J Biochem       Date:  1989-12-22

9.  Tetrahydroaminoacridine and other allosteric antagonists of hippocampal M1 muscarine receptors.

Authors:  L T Potter; C A Ferrendelli; H E Hanchett; M A Hollifield; M V Lorenzi
Journal:  Mol Pharmacol       Date:  1989-05       Impact factor: 4.436

10.  Gallamine allosterically antagonizes muscarinic receptor-mediated inhibition of adenylate cyclase activity in the rat myocardium.

Authors:  F J Ehlert
Journal:  J Pharmacol Exp Ther       Date:  1988-11       Impact factor: 4.030

View more
  30 in total

1.  Comparative pharmacology of recombinant human M3 and M5 muscarinic receptors expressed in CHO-K1 cells.

Authors:  N Watson; D V Daniels; A P Ford; R M Eglen; S S Hegde
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  G(q/11) and G(i/o) activation profiles in CHO cells expressing human muscarinic acetylcholine receptors: dependence on agonist as well as receptor-subtype.

Authors:  E C Akam; R A Challiss; S R Nahorski
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

Review 3.  Functional M3 muscarinic acetylcholine receptors in mammalian hearts.

Authors:  Zhiguo Wang; Hong Shi; Huizhen Wang
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

Review 4.  Use of the GTPγS ([35S]GTPγS and Eu-GTPγS) binding assay for analysis of ligand potency and efficacy at G protein-coupled receptors.

Authors:  Philip G Strange
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

5.  Segment-dependent expression of muscarinic acetylcholine receptors and G-protein coupling in the equine respiratory tract.

Authors:  G Abraham; C Kottke; H Ammer; S Dhein; F R Ungemach
Journal:  Vet Res Commun       Date:  2006-12-15       Impact factor: 2.459

6.  Preclinical characterization of WAY-211612: a dual 5-HT uptake inhibitor and 5-HT (1A) receptor antagonist and potential novel antidepressant.

Authors:  C E Beyer; Q Lin; B Platt; J Malberg; G Hornby; K M Sullivan; D L Smith; T Lock; P J Mitchell; N T Hatzenbuhler; D A Evrard; B L Harrison; R Magolda; M N Pangalos; L E Schechter; S Rosenzweig-Lipson; T H Andree
Journal:  Br J Pharmacol       Date:  2009-03-26       Impact factor: 8.739

7.  Spontaneously hypertensive rats cholinergic hyper-responsiveness: central and peripheral pharmacological mechanisms.

Authors:  E Lazartigues; C Brefel-Courbon; M A Tran; J L Montastruc; O Rascol
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

8.  Modulation by neurotransmitters of catecholamine secretion from sympathetic ganglion neurons detected by amperometry.

Authors:  D S Koh; B Hille
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

9.  A single receptor encoded by vzg-1/lpA1/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid.

Authors:  N Fukushima; Y Kimura; J Chun
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

10.  Selectivity of agonists for the active state of M1 to M4 muscarinic receptor subtypes.

Authors:  Katherine W Figueroa; Michael T Griffin; Frederick J Ehlert
Journal:  J Pharmacol Exp Ther       Date:  2008-09-29       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.